Dr. Maron on the Role of PD-1 Inhibition in Esophagogastric Cancer
Steven Maron, MD, MSc, discusses the role of PD-1 inhibition in esophagogastric cancer.
Dr. Maron on Sequencing Considerations in the Frontline Treatment of GI Cancers
Steven Maron, MD, MSc, discusses sequencing considerations in the frontline treatment of gastrointestinal cancers.
Dr. Maron on HER2-Positive Tumors in Esophageal Gastric Cancers
Steven Maron, MD, MSc, discusses HER2-positive tumors in esophageal gastric cancers.
Dr Cook on Real-World Data With Bridging Therapy and Axi-Cel in Relapsed/Refractory LBCL
Dr Goy on Outcomes From An Expanded Access Study of Brexu-Cel in Relapsed/Refractory MCL
Ide-Cel Provides HRQOL Benefits Over Standard Regimens in R/R Multiple Myeloma
Bridging Therapy Prior to Axi-Cel Produces Favorable Real-World Outcomes in R/R LBCL
2 Clarke Drive Cranbury, NJ 08512